| English Alias: |
acycloguanosine;2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6h-purin-6-one;2-AMINO-9-(2-HYDROXY-ETHOXYMETHYL)-1,9-DIHYDRO-PURIN-6-ONE;ACICLOVIR;ACV;ACYCLOVIR;ACYCLOVIR SUBST;AKOS NCG1-0055;1,9-dihydro-2-amino-9-((2-hydroxyethoxy)methyl)-6h-purin-6-on;2-amino-1,9-dihydro-9-((2-hydroxyethoxy)-methyl)-6h-purin-6-on;aciclovirum(latin);aclovir;Acycolguanosine;vipral;virorax;w-248-u;Acyclovir (Patented-No Supply);N(9)-Oxyethoxymethylguanine (Acyclovir);9-[(2-Hydroxyethoxy)Methyl]Guanine;2-Amino-9-((2-hydroxyethoxy)methyl)-1H-purin-6(9H)-one;Poviral;Vimrax;Zoviax;Zyclir;Zovirax;Aciclovirum;Zovir;Aciclovirum [Latin];Sitavig;Aciclovier;9-HYROXYETHOXYMETHYLGUANINE;Aciclovirum [INN-Latin];9-(2-Hydroxyethoxy)methylguanine;9-((2-Hydroxyethoxy)methyl)guanine;Acicloftal;Cargosil;Acyclovir-side chain-2-3H;2-ami;Acyclovir;IDI1_000185;2-amino-9-[(2-hydroxyethoxy)methyl]hydropurin-6-one;NSC645011;A832236;NS00009000;6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-;Opera_ID_1674;ACICLOVIR [JAN];AM20100442;KBioGR_000889;2-Amino-9-(2-hydroxy-ethoxymethyl)-5,9-dihydro-purin-6-one;2-amino-9-((2-hydroxyethoxy)methyl)-3H-purin-6(9H)-one;NINDS_000185;AKOS022135433;Activir;2-azanyl-9-(2-hydroxyethyloxymethyl)-3H-purin-6-one;Acyclovir, United States Pharmacopeia (USP) Reference Standard;2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one;UNII-X4HES1O11F;2-amino-9-(2-hydroxyethoxymethyl)-1H-purin-6-one;NSC-780378;Genvir;NCGC00015061-05;Aciclovir 1.0 mg/ml in Dimethyl Sulfoxide;Acic;2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one #;2-amino-9-((2-hydroxyethoxy)methyl)-1,9-dihydro-6H-purin-6-one;NCGC00015061-07;SY051130;Maynar;Cyclovir;Prestwick3_000086;BIDD:GT0646;DTXSID1022556;9(2-hydroxyethoxymethyl)guanine;CCG-39909;VALACICLOVIR HYDROCHLORIDE HYDRATE IMPURITY B [EP IMPURITY];KBioSS_002219;Acyclovir (Aciclovir);2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one;NCGC00015061-29;KBio2_004787;Aciclovir, British Pharmacopoeia (BP) Reference Standard;Acyclovir (USAN:USP);NSC 645011;Spectrum_001739;BSPBio_003348;Aciclovir for peak identification 1, European Pharmacopoeia (EP) Reference Standard;Q147101;HY-17422;NCGC00015061-12;HMS2234K21;BW-248-U;AKOS000656213;NCGC00015061-09;HMS1568A14;ACYCLOVIR (USP-RS);NCGC00015061-01;Tox21_500037;ACV; Acycloguanosine; Acyclovir; NSC 645011; NSC-645011; NSC645011;2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one;Tox21_110075;BDBM50021776;NCGC00093555-04;88713-38-6;A 4669;BRD-K32318651-001-17-9;NCGC00015061-13;Aciclovir for peak identification 2, European Pharmacopoeia (EP) Reference Standard;ACICLOVIR (IARC);NSC758477;s1807;NCGC00015061-03;Acyclovir [USAN];KBio2_002219;Zovirax (TN);DRG-0008;Acyclovir, Pharmaceutical Secondary Standard; Certified Reference Material;69657-51-8 (Na salt);NSC335752;SW196324-3;VALACICLOVIR HYDROCHLORIDE IMPURITY B (EP IMPURITY... |
